Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT04318392
Eligibility Criteria:
Participants with Suspected Sarcoidosis:
Inclusion Criteria:
* Age \>18 years
* Suspected pulmonary sarcoidosis undergoing investigations for diagnosis, staging and treatment consideration or discussion at a designated interstitial lung disease multidisciplinary meeting (this includes participants with stage I disease characterised by the presence of hilar or mediastinal lymphadenopathy)
Exclusion Criteria:
* Significant respiratory co-morbidity where the primary major respiratory diagnosis is not sarcoidosis
* Current smoker or ex-smoker (having ceased smoking \<3 months duration)
* Extra-pulmonary sarcoidosis without any evidence of pulmonary involvement (characterised by normal pulmonary function tests and no radiological evidence of thoracic sarcoidosis on HRCT or chest radiography)
* Inability to provide written consent
* Self-reported lower respiratory tract infection, or treatment with antibiotics for a lower respiratory tract infection or any other infection within the previous 4 weeks
Healthy Volunteers:
Inclusion Criteria:
* Age \>18 - 70 years
* Normal spirometry
Exclusion Criteria:
* Current smoker or ex-smoker (having ceased smoking \<3 months duration)
* History of uncontrolled diabetes, respiratory, inflammatory gastroenterological, autoimmune or renal disease (characterised by an eGFR \<30ml/min/1.73m2)
* Self-reported lower respiratory tract infection, or treatment with antibiotics for a lower respiratory tract infection or any other infection within the previous 4 weeks
* Inability to provide written consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04318392
Study Brief:
Protocol Section:
NCT04318392